Ignite Creation Date:
2025-12-24 @ 10:14 PM
Ignite Modification Date:
2026-05-09 @ 4:56 PM
Study NCT ID:
NCT04416035
Status:
UNKNOWN
Last Update Posted:
2020-08-31
First Post:
2020-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC
Sponsor:
Zhejiang Teruisi Pharmaceutical Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Non-squamous Non-small-cell Lung Cancer | View |
Keywords: